Patients with chronic obstructive pulmonary disease (COPD) and reduced physical activity showed a higher risk of emergency department visits or hospitalizations in a recent study. Patients with ...
Treatment with Nucala, an interleukin-5 antagonist monoclonal antibody, significantly reduced exacerbations leading to hospitalizations and emergency department visits. The Food and Drug ...
PhD Candidate in Management (concentration in Health Systems), L’Université d’Ottawa/University of Ottawa Andrew D. Scarffe (he/him) received funding from the Asthma Research Group Windsor-Essex ...
I overheard the EMS radio calling in to the emergency department and could immediately hear the urgency in the voice of the paramedic about a patient being brought in. He told us they were bringing in ...
GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...